Relative Bioavailability of Two Orally Administered CBD Formulations in Healthy Male Adults

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

Canada

University of Saskatchewan, Saskatoon, Saskatchewan